Skip to search.
 FTSE 100 Down 0.08%

Gilead Sciences Inc. (GILD)

-NasdaqGS
112.37 Down 0.48(0.43%) 15:27 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:112.85
Open:113.18
Bid:112.23 x 200
Ask:112.24 x 300
1y Target Est:121.57
Beta:0.93
Earnings Date:21 Jul - 27 Jul (Est.)
Day's Range:112.11 - 113.37
52wk Range:78.50 - 116.83
Volume:2,176,776
Avg Vol (3m):11,071,000
Market Cap:165.14b
P/E (ttm):12.81
EPS (ttm):8.77
Div & Yield:1.72 (1.70%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.43%165.14b
GSKDown 0.42%107.71b
PFEUp 0.69%213.54b
RHHBYDown 0.20%N/A

Key Statistics

Forward P/E (1 yr):10.19
P/S (ttm):6.03
Ex-Dividend Date:12-Jun-15

Analysts

Annual EPS Est (Dec-15) :10.84
Quarterly EPS Est (Jun-15) :2.66
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.78

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback